| The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo … C Baigent, MJ Landray, C Reith, J Emberson, DC Wheeler, C Tomson, ... The Lancet 377 (9784), 2181-2192, 2011 | 2961 | 2011 |
| Rosuvastatin and cardiovascular events in patients undergoing hemodialysis BC Fellström, AG Jardine, RE Schmieder, H Holdaas, K Bannister, ... New England Journal of Medicine 360 (14), 1395-1407, 2009 | 2323 | 2009 |
| Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial H Holdaas, B Fellström, AG Jardine, I Holme, G Nyberg, P Fauchald, ... The Lancet 361 (9374), 2024-2031, 2003 | 1083 | 2003 |
| Long-term risks for kidney donors G Mjøen, S Hallan, A Hartmann, A Foss, K Midtvedt, O Øyen, A Reisæter, ... Kidney international 86 (1), 162-167, 2014 | 830 | 2014 |
| Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials J Armitage, C Baigent, E Barnes, DJ Betteridge, L Blackwell, M Blazing, ... The Lancet 393 (10170), 407-415, 2019 | 702 | 2019 |
| Risk for myopathy with statin therapy in high-risk patients CM Ballantyne, A Corsini, MH Davidson, H Holdaas, TA Jacobson, ... Archives of internal medicine 163 (5), 553-564, 2003 | 594 | 2003 |
| The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events J Hjelmesaeth, A Hartmann, T Leivestad, H Holdaas, S Sagedal, M Olstad, ... Kidney international 69 (3), 588-595, 2006 | 432 | 2006 |
| Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease Sharp Collaborative Group American heart journal 160 (5), 785-794. e10, 2010 | 414 | 2010 |
| Long‐term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study H Holdaas, B Fellström, E Cole, G Nyberg, AG Olsson, TR Pedersen, ... American Journal of Transplantation 5 (12), 2929-2936, 2005 | 374 | 2005 |
| Prevention of cardiovascular disease in adult recipients of kidney transplants AG Jardine, RS Gaston, BC Fellstrom, H Holdaas The Lancet 378 (9800), 1419-1427, 2011 | 339 | 2011 |
| Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy Cholesterol Treatment Trialists'(CTT) Collaboration PloS one 7 (1), e29849, 2012 | 319 | 2012 |
| Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials W Herrington, J Emberson, B Mihaylova, L Blackwell, C Reith, R Haynes, ... Lancet Diabetes and Endocrinology 4 (10), 2016 | 212 | 2016 |
| Effects of lowering LDL cholesterol on progression of kidney disease R Haynes, D Lewis, J Emberson, C Reith, L Agodoa, A Cass, JC Craig, ... Journal of the American Society of Nephrology 25 (8), 1825-1833, 2014 | 194 | 2014 |
| Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis W März, B Genser, C Drechsler, V Krane, TB Grammer, E Ritz, ... Clinical Journal of the American Society of Nephrology 6 (6), 1316-1325, 2011 | 183 | 2011 |
| Renal adrenoceptor mediation of antinatriuretic and renin secretion responses to low frequency renal nerve stimulation in the dog. JL Osborn, H Holdaas, MD Thames, GF DiBona Circulation research 53 (3), 298-305, 1983 | 180 | 1983 |
| Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus WPD Lemahieu, M Hermann, A Asberg, K Verbeke, H Holdaas, ... American Journal of Transplantation 5 (9), 2236-2243, 2005 | 166 | 2005 |
| Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation TG Valderhaug, T Jenssen, A Hartmann, K Midtvedt, H Holdaas, ... Transplantation 88 (3), 429-434, 2009 | 161 | 2009 |
| Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial B Fellström, H Holdaas, AG Jardine, I Holme, G Nyberg, P Fauchald, ... Kidney international 66 (4), 1549-1555, 2004 | 160 | 2004 |
| Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study AG Jardine, B Fellström, JO Logan, E Cole, G Nyberg, ... American journal of kidney diseases 46 (3), 529-536, 2005 | 158 | 2005 |
| Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study H Holdaas, L Rostaing, D Serón, E Cole, J Chapman, B Fellstrøm, ... Transplantation 92 (4), 410-418, 2011 | 157 | 2011 |
